Health Condition 1: D66- Hereditary factor VIII deficiency
Conditions
Interventions
None listed
Sponsors
Sanofi Aventis Groupe
Kantar
Eligibility
Inclusion criteria
Inclusion criteria: Patients who had participated in phase 3 would be selected from 3 sites. By recruiting patients from multiple sites in India, it is anticipated that the interview substudy sample will be somewhat representative of the overall clinical trial population in India. No patient (or caregiver) clinical or demographic characteristics will be targeted during sample selection.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To know the experiences of patients who have participated in phase 3 clinical trialTimepoint: after 1 year of 1st recruitment | — |
Secondary
| Measure | Time frame |
|---|---|
| To know the experiences of patients who have participated in phase 3 clinical trialTimepoint: after 1 year of 1st recruitment | — |
Countries
India
Contacts
Public ContactDr Savita Rangarajan
K J Somaiya Hospital and Research Center
Outcome results
None listed